Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CT/Norwich
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Norwich, CT

Studies commonly pay $75 to $4,500 per completed study

123 clinical trials are currently recruiting participants within 30 miles of Norwich. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

123studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Norwich right now

Top 25 of 123 recruiting studies, sorted by proximity — each links to its official registry page

A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia

Hemiplegia, Cerebral Palsy N/A Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (19.7 mi) · Sponsor: University of Connecticut
See eligibility & contact on ClinicalTrials.gov (NCT06579027)

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Diabetic Macular Edema Phase 1, Phase 2 Interventional 49 participants sought
Retina Group of New England, PC — Waterford, Connecticut (14.6 mi) · Sponsor: Boehringer Ingelheim
See eligibility & contact on ClinicalTrials.gov (NCT07553429)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Transthyretin Amyloidosis With Cardiomyopathy Phase 3 Interventional 1,750 participants sought
Clinical Trial Site — Norwich, Connecticut (1.9 mi) · Sponsor: Alnylam Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07052903)

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

Advanced Solid Tumors, Metastatic Solid Tumors Phase 1, Phase 2 Interventional 370 participants sought
Eastern Connecticut Hematology and Oncology Associates — Norwich, Connecticut (1.9 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07397338)

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

Fibromyalgia Phase 3 Interventional 620 participants sought
Clinical Research Site — Cromwell, Connecticut (29.0 mi) · Sponsor: Axsome Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07398417)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
William W. Backus Hospital — Norwich, Connecticut (1.9 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Age-related Wet Macular Degeneration Phase 1 Interventional 45 participants sought
CBCC Global Research Site:005 — Manchester, Connecticut (27.3 mi) · Sponsor: Caregen Co. Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06132035)

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

Resectable Intrahepatic Cholangiocarcinoma Phase 2 Interventional 27 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06050252)

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer N/A Observational 200 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: Abramson Cancer Center at Penn Medicine
See eligibility & contact on ClinicalTrials.gov (NCT06551116)

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD) N/A Interventional 100 participants sought
Retina Consultants PC — Manchester, Connecticut (27.3 mi) · Sponsor: i-Lumen Scientific AUS PTY LTD
See eligibility & contact on ClinicalTrials.gov (NCT06662162)

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer (CRC) Phase 3 Interventional 600 participants sought
Clinical Study Site — Norwich, Connecticut (1.9 mi) · Sponsor: Summit Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT07228832)

Integrated Cancer Repository for Cancer Research

Multiple conditions N/A Observational 999,999 participants sought
Hartford HealthCare Cancer Institute at Manchester Medical Hospital — Manchester, Connecticut (27.3 mi) · Sponsor: University of Nebraska
See eligibility & contact on ClinicalTrials.gov (NCT02012699)

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Metastatic Colorectal Cancer Phase 1 Interventional 542 participants sought
Eastern Ct Hema/Onco Assoc — Norwich, Connecticut (1.9 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT04929223)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Hartford HealthCare - Manchester — Manchester, Connecticut (27.3 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Retina Consultants — Manchester, Connecticut (27.3 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT05844982)

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 680 participants sought
Eastern CT Hematology & Oncology Associates ( Site 0202) — Norwich, Connecticut (1.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06623422)

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

Neovascular Age-Related Macular Degeneration (nAMD) Phase 3 Interventional 850 participants sought
Retina Group of New England — Waterford, Connecticut (14.6 mi) · Sponsor: Ocular Therapeutix, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07516132)

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) Phase 2 Interventional 315 participants sought
Connecticut Clinical Research - Cromwell /ID# 271241 — Cromwell, Connecticut (29.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06846320)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Smilow Cancer Hospital Care Center - Waterford — Waterford, Connecticut (14.6 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Cardiotoxicity, HER2/Neu Positive Phase 3 Interventional 491 participants sought
Middlesex Hospital — Middletown, Connecticut (29.1 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03418961)
Actively enrolling

Studies you may be able to join near Norwich

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Norwich

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Comprehensive Research Center

200 W Town St, Norwich, CT 06360
(860) 886-1508 ext. 23

Eastern Connecticut Hematology and Oncology

★ 4.7 (215 reviews)
Medical Office Building, 330 Washington St STE 220, Norwich, CT 06360
(860) 886-8362
"It was a good visit informational and understood all that was told to me"
— Milton Poppie, 4★

Coastal Connecticut Research

★ 5.0
342 Montauk Ave, New London, CT 06320
(860) 437-7092
"Clinical trials and research studies for multiple sclerosis, alzheimer's, overactive bladder, hot flashes, and birth control, Friendly, caring, kn…"
— Sindi Mannochi, 5★

ECHO Cancer Foundation

★ 5.0
330 Washington St, Norwich, CT 06360
(860) 460-9722

CT Clinical Research

160 West St Ste 1A, Cromwell, CT 06416
(860) 632-0144

Chase Medical Research, LLC

★ 5.0
1952 Whitney Ave, Hamden, CT 06517
(203) 419-4404
"I would like to start by saying that stuff are amazing there. Special thanks to three very professional and cool at the same time ladies Amanda, Sam…"
— Denise Mizla, 5★

Clinical Trials of New England

1234 Hyde Park Ave #205, Hyde Park, MA 02136

Clinical Trials

100 Retreat Ave, Hartford, CT 06106
(860) 244-0148

Clinical Research Consulting LLC

★ 4.0
2080 Bridgeport Ave D, Milford, CT 06460
(203) 386-3115
"Just finishing up a research study with them, they are all very friendly and organized. They are efficient and do a good job of getting you in and ou…"
— Stephen Callahan, 5★

Clinical trials in Norwich: what's recruiting

The Norwich area currently has 123 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Norwich, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular3 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Norwich, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Norwich

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Norwich participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Norwich?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Norwich safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Norwich, CT?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Norwich?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Norwich.

Paid clinical trials near Norwich

Other metros within reach

Hartford, CT441 Providence, RI558 Springfield, MA317 Worcester, MA273 New Haven, CT1,174 Waterbury, CT1,134 New Bedford, MA519 Bridgeport, CT1,445

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Norwich Bladder Issues Due To Spinal Cord Injury in Norwich All conditions

More of CT

Bridgeport1,445 New Haven1,174 Danbury1,147 Waterbury1,134 Hartford441

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts